W, F., J, C., A, R., R, S., E, G., C, T., . . . P, M. (2026). Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-70133-8
Chicago Style (17th ed.) CitationW, Fernando, et al. "Necroptosis in Both Tumour and Stromal Compartments Determines Responsiveness to Immunogenic Cell Death-based Immunotherapy." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-70133-8.
MLA (9th ed.) CitationW, Fernando, et al. "Necroptosis in Both Tumour and Stromal Compartments Determines Responsiveness to Immunogenic Cell Death-based Immunotherapy." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-70133-8.